治疗 2 型糖尿病的 SGLT2 抑制剂 Empagliflozin

{"title":"治疗 2 型糖尿病的 SGLT2 抑制剂 Empagliflozin","authors":"Catarina Gamito, Chiara La Guidara, João R. Costa","doi":"10.52590/m3.p709.a30002770","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":496356,"journal":{"name":"Boletim da Sociedade Portuguesa de Química","volume":"43 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Empagliflozina, Inibidor do SGLT2 no Tratamento da Diabetes do Tipo 2\",\"authors\":\"Catarina Gamito, Chiara La Guidara, João R. Costa\",\"doi\":\"10.52590/m3.p709.a30002770\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":496356,\"journal\":{\"name\":\"Boletim da Sociedade Portuguesa de Química\",\"volume\":\"43 12\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Boletim da Sociedade Portuguesa de Química\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.52590/m3.p709.a30002770\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Boletim da Sociedade Portuguesa de Química","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.52590/m3.p709.a30002770","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}